Sanofi ADR Net Worth

Sanofi ADR Net Worth Analysis

Know Sanofi ADR's Top Institutional Investors

Note, although Sanofi ADR's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Sanofi ADR's market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 118.67 B.

Project Sanofi ADR's profitablity

The company has Net Profit Margin of 0.14 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.21 %, which entails that for every 100 dollars of revenue, it generated $0.21 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Sanofi ADR's management efficiency

Sanofi ADR has Return on Asset of 0.0428 % which means that on every $100 spent on assets, it made $0.0428 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.073 %, implying that it generated $0.073 on every 100 dollars invested. Sanofi ADR's management efficiency ratios could be used to measure how well Sanofi ADR manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sanofi ADR's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.08 in 2025, whereas Return On Capital Employed is likely to drop 0.07 in 2025. At this time, Sanofi ADR's Other Current Assets are fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.14 in 2025, whereas Total Assets are likely to drop slightly above 90.7 B in 2025.

Sanofi ADR Corporate Filings

Sanofi ADR time-series forecasting models is one of many Sanofi ADR's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sanofi ADR's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Sanofi ADR Earnings per Share Projection vs Actual

Sanofi ADR Corporate Management

Additional Tools for Sanofi Stock Analysis